Physician profile
Joel L Ramirez
NPI 1659832863
$4,879.14
in general payments reported to CMS, 2019-2025
6 companies · $3,341 in 2025
The $3,341 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $805 · 2022: $312 · 2024: $421 · 2025: $3,341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,100 · Food and Beverage: $1,511 · Travel and Lodging: $101 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,100.00 |
| Food and Beverage | $1,510.67 |
| Travel and Lodging | $101.21 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,823.33 | 2021-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $1,174.43 | 2021-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Cook Medical LLC | $454.24 | 2024-2025 | Zenith, Zenith Alpha, Cook |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Silk Road Medical, INC. | $94.15 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $27.99 | 2025 | Accolade Sr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.